{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:42:48Z","timestamp":1648762968507},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00120-021-01552-2","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T09:06:29Z","timestamp":1623143189000},"page":"1184-1187","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intraabdominelle BCG-Granulomatose (Bacillus Calmette-Gu\u00e9rin) nach okkulter Blasenperforation"],"prefix":"10.1007","volume":"60","author":[{"given":"L.","family":"Lawaczeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. K.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Norz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bedke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Amend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"1552_CR1","unstructured":"S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms, Langversion 2.01, September 2019, AWMF-Registernummer: 032\/038OL"},{"key":"1552_CR2","first-page":"623","volume":"187","author":"S Kaufmann","year":"2015","unstructured":"Kaufmann\u00a0S et al (2015) Bacillus-Calmette-Gu\u00e9rin-Infektion (BCGitis) nach intravesikaler BCG-Instillationstherapie bei Urothelkarzinom der Harnblase. R\u00f6Fo 187:623\u2013626","journal-title":"R\u00f6Fo"},{"key":"1552_CR3","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/S0022-5347(06)00264-3","volume":"6","author":"MP Koya","year":"2006","unstructured":"Koya\u00a0MP et\u00a0al (2006) Complications of Intravesical therapy for urothelial cancer of the bladder. J\u00a0Urol 6:2004\u20132010","journal-title":"J Urol"},{"key":"1552_CR4","doi-asserted-by":"publisher","unstructured":"Soylu A et al (2009) Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Gu\u00e9rin. Ann Clin Microbiol Antimicrob 8(12). https:\/\/doi.org\/10.1186\/1476-0711-8-12","DOI":"10.1186\/1476-0711-8-12"},{"key":"1552_CR5","first-page":"352","volume":"23","author":"A Shapiro","year":"2005","unstructured":"Shapiro\u00a0A et al (2005) Diffuse granulomatous mesenteric disease caused by intravesical bacillus Calmette-Gu\u00e9rin instillation masquerading as peritoneal carcinomatosis. Urol Oncol Seminars Orig Investig 23:352\u2013353","journal-title":"Urol Oncol Seminars Orig Investig"},{"key":"1552_CR6","unstructured":"Falldefinitionen des Robert-Koch-Instituts zur \u00dcbermittlung von Erkrankungs- oder Todesf\u00e4llen und Nachweisen von Krankheitserregern (Ausgabe 2015)"},{"key":"1552_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s00120-020-01237-2","volume":"59","author":"T Todenh\u00f6fer","year":"2020","unstructured":"Todenh\u00f6fer\u00a0T, Boegemann\u00a0M (2020) Immunonkologische Therapie des Harnblasenkarzinoms \u2013 quo vadis? Update zu aktuellen Studien und weiteren Entwicklungen. Urologe 59:810\u2013816","journal-title":"Urologe"},{"key":"1552_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s00120-020-01233-6","volume":"59","author":"MW Kramer","year":"2020","unstructured":"Kramer\u00a0MW, Gakis\u00a0G (2020) Immunonkologische Therapieoptionen des nicht-muskelinvasiven Urothelkarzinoms. Urologe 59:784\u2013789","journal-title":"Urologe"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-021-01552-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-021-01552-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-021-01552-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T14:04:58Z","timestamp":1629900298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-021-01552-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1552"],"URL":"https:\/\/doi.org\/10.1007\/s00120-021-01552-2","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"23 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Lawaczeck, A.\u00a0K.\u00a0Fischer, V.\u00a0Norz, S.\u00a0Rausch, J.\u00a0Bedke, A.\u00a0Stenzl und B.\u00a0Amend geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}